Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Synthetic Anti-infective Drugs >  Antiviral drugs >  Tenofovir alafenamide hemifumarate

Tenofovir alafenamide hemifumarate

Basic information Safety Supplier Related

Tenofovir alafenamide hemifumarate Basic information

Product Name:
Tenofovir alafenamide hemifumarate
Synonyms:
  • L-Alanine,N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-, 1-methylethyl ester, (2E)-2-butenedioate (2:1)
  • N-[(S)-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-L-alanine 1-methylethyl ester (2E)-2-butenedioate (2:1)
  • GS-7340 (hemifumarate)
  • TENOFOVIR ALAFENAMIDE HEMIFUMARATE (GS-7340 HEMIFUMARATE)
  • Tenofovir levamide amine fumarate
  • GS7340(Tenofovir Alafenamide Fumarate)
  • (Tenofovir alafenamide : fumarate = 2:1)
  • Anti-HIV
CAS:
1392275-56-7
MF:
C25H33N6O9P
MW:
592.55
EINECS:
805-448-8
Product Categories:
  • API
  • 1392275-56-7
Mol File:
1392275-56-7.mol
More
Less

Tenofovir alafenamide hemifumarate Chemical Properties

storage temp. 
Keep in dark place,Sealed in dry,Room Temperature
solubility 
DMSO:75.0(Max Conc. mg/mL);70.16(Max Conc. mM)
form 
Solid
color 
White to off-white
CAS DataBase Reference
1392275-56-7
More
Less

Tenofovir alafenamide hemifumarate Usage And Synthesis

Description

Tenofovir alafenamide hemifumarate is an investigational oral prodrug of Tenofovir. Tenofovir is a HIV-1 nucleotide reverse transcriptase inhibitor.

Chemical Properties

White to almost White crystal or crystalline powder.

Originator

Gilead Sciences

Uses

Tenofovir alafenamide hemifumarate is a newer, more effective prodrug used in combination with FTC that has recently been approved for the prevention of HIV transmission through the rectum. It is used to treat chronic hepatitis B virus (HBV) infection in adults with compensated liver disease.

Definition

ChEBI: Tenofovir alafenamide fumarate is a fumarate salt prepared from tenofovir alafenamide by reaction of one molecule of fumaric acid for every two molecules of tenofovir alafenamide. A prodrug for tenofovir, it is used in combination therapy for the treatment of HIV-1 infection. It has a role as an antiviral drug, a HIV-1 reverse transcriptase inhibitor and a prodrug. It contains a tenofovir alafenamide(1+).

Clinical Use

Tenofovir alafenamide hemifumarate is useful in the treatment and/or prophylaxis of one or more viral infections in man or animals, including infections caused by DNA viruses. RNA viruses, herpesviruses (e.g., CMV, HSV 1, HSV 2, VZV), retroviruses, hepadnaviruses (e.g., HBV), papillomavirus, hantavirus, adenoviruses and HIV. Like tenofovir disoproxil, tenofovir alafenamide is another prodrug form of tenofovir, and can be used in the treatment and/or prophylaxis of the same conditions.

Side effects

Check with your doctor immediately if any of the following side effects occur:
Abdominal or stomach discomfort,bloody urine,dark urine,decreased appetite,decreased frequency or amount of urine,troubled breathing,cough,headache,back pain.

Synthesis

Under a nitrogen atmosphere, 200 g of isopropanol, 9 g of fumaric acid, and 50 g of TAF-3 were sequentially added to a 2 L reaction flask. Turn on the stirring, control the temperature at 40 ~ 50 °C, stir and dissolve, filter while hot, collect the mother liquor. Transfer the mother liquor to a 2L reaction bottle, start stirring, control the temperature at 40 ~ 50 °C, stir and dissolve, slowly reduce the temperature to 0 ~ 5 ° C, cooling time 2 ~ 3 hours, heat stirring for 10 hours. Filtration, drying at 60-65 ° C for 12 to 16 hours, to obtain 37.5 g of Tenofovir Alafenamide Fumarate finished product, white powder, yield 75.0%.

Drug interactions

Some products that may interact with this drug are: adefovir, orlistat, other drugs that may harm the kidneys (including aminoglycosides such as amikacin/gentamicin).

Advantages

One major advantage of the hemifumarate form of tenofovir alafenamide over the monofumarate form is its exceptional capability to purge GS-7339 (i.e., 9-[(R)-2-[[(R)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]phenoxyphosphinyl]methoxy]propyl]adenine, which is the major diastereomeric impurity in the active pharmaceutical ingredient. Thus, the hemifumarate form of tenofovir alafenamide can be more readily and easily separated from impurities than the monofumarate form. Other major advantages of tenofovir alafenamide hemifumarate over the monofumarate form include improved thermodynamic and chemical stability (including long-term storage stability), superior process reproducibility, superior drug product content uniformity, and a higher melting point.

Tenofovir alafenamide hemifumarateSupplier

Xiamen Halosyntech Co., Ltd Gold
Tel
0592-6688068 18106901346
Email
qbl2015@halolife.cn
Jinan XinKe Pharmaceutical Technology Co., Ltd. Gold
Tel
0531-88259693 17854196142
Email
2820602043@qq.com
Huangshi Fuertai Pharmaceutical Tech Co., Ltd. Gold
Tel
0714-3293168-6021 13995956430
Email
fuertaixia@foxmail.com
Shanghai Peiling Biological Technology Co., LTD Gold
Tel
13127581762
Email
peilingchem@sina.com
HUBEI HICKS BIOCHEMICAL CO.,LTD Gold
Tel
18696113233
Email
15927219311@163.com